FEAF
TPEx

6419 京晨科

130.50 ▲ 9.50 (7.85%) Close · 2026-11-13 · TPEx
Ask about 6419
This is research, not a buy or sell recommendation. Robo-advice in Taiwan requires an FSC licence; FEAF analyses, explains and monitors, and the investor makes the decision. Judgement thresholds are working rules pending review by the team's finance members.

Plain-language summary of valuation, growth, profitability, balance sheet, and recent MOPS filings.

Your risk profile
Conclusion

Mixed picture: 2 strengths against 2 watch-outs. Weigh them against your own goals.

Points to watch for a moderate profile: see the items marked above.

No model narrative: the model call failed. The structured analysis above is complete on its own.

Strengths

+ Return on equity 49.0% with a 28.5% net margin: highly profitable. source (Key Stats) →
+ Free cash flow was positive in 2025: 50 NT$ million. source (Financials) →

Watch-outs

! The current price implies 4.0% perpetual growth, above the 3.5% ceiling: the price already assumes high expectations. source (Valuation) →
! Revenue fell -35.8% in 2025; latest quarter Q3 2026: 414.4% year on year. source (Financials) →

What to check before deciding

?Can the company sustain growth above the perpetual-growth ceiling for years?
?Is the revenue decline temporary or structural?

What the analysis found

! Valuation (DCF) The current price implies 4.0% perpetual growth, above the 3.5% ceiling: the price already assumes high expectations. source →
! Growth Revenue fell -35.8% in 2025; latest quarter Q3 2026: 414.4% year on year. source →
+ Profitability Return on equity 49.0% with a 28.5% net margin: highly profitable. source →
· Debt Liabilities are 45.8% of total assets (Q3 2026). source →
+ Cash flow Free cash flow was positive in 2025: 50 NT$ million. source →
· Filings 2 verified alert(s); latest on 2026-11-13: 本公司董事會通過115年第3季財務報告 source →